DeSantis CE, Ma J, Gaudet MM et al (2019) Breast cancer statistics. CA Cancer J Clin 69:438–451. https://doi.org/10.3322/caac.21583

Article  PubMed  Google Scholar 

Cardoso F, Kyriakides S, Ohno S et al (2019) Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol 30:1194–1220. https://doi.org/10.1093/annonc/mdz173

Article  CAS  PubMed  Google Scholar 

van Dongen JA, Voogd AC, Fentiman IS et al (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst 92:1143–1150. https://doi.org/10.1093/jnci/92.14.1143

Article  PubMed  Google Scholar 

Peng G, Zhou Z, Jiang M, Yang F (2019) Can a subgroup at high risk for LRR be identified from T1–2 breast cancer with negative lymph nodes after mastectomy? A meta-analysis. Biosci Rep. https://doi.org/10.1042/BSR20181853

Yang SH, Yang KH, Li YP et al (2008) Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials. Ann Oncol 19:1039–1044. https://doi.org/10.1093/annonc/mdm573

Article  CAS  PubMed  Google Scholar 

Rouzier R, Extra JM, Carton M et al (2001) Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol 19:3828–3835. https://doi.org/10.1200/JCO.2001.19.18.3828

Article  CAS  PubMed  Google Scholar 

Hattangadi-Gluth JA, Wo JY, Nguyen PL et al (2012) Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. Int J Radiat Oncol Biol Phys 82:1185–1191. https://doi.org/10.1016/j.ijrobp.2011.02.061

Article  PubMed  Google Scholar 

Zumsteg ZS, Morrow M, Arnold B et al (2013) Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1–2N0 triple-negative breast cancer. Ann Surg Oncol 20:3469–3476. https://doi.org/10.1245/s10434-013-3011-9

Article  PubMed  PubMed Central  Google Scholar 

Lowery AJ, Kell MR, Glynn RW et al (2012) Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat 133:831–841. https://doi.org/10.1007/s10549-011-1891-6

Article  PubMed  Google Scholar 

Wapnir IL, Price KN, Anderson SJ et al (2018) Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial. J Clin Oncol 36:1073–1079. https://doi.org/10.1200/JCO.2017.76.5719

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Bock GH, van der Hage JA, Putter H et al (2006) Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European organisation for research and treatment of cancer studies. Eur J Cancer 42:351–356. https://doi.org/10.1016/j.ejca.2005.10.006

Article  PubMed  Google Scholar 

Kurtz JM, Amalric R, Brandone H et al (1989) Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer 63:1912–1917. https://doi.org/10.1002/1097-0142(19890515)63:10%3c1912::aid-cncr2820631007%3e3.0.co;2-y

Article  CAS  PubMed  Google Scholar 

Fisher B, Anderson S, Redmond CK et al (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333:1456–1461. https://doi.org/10.1056/NEJM199511303332203

Article  CAS  PubMed  Google Scholar 

Wapnir IL, Anderson SJ, Mamounas EP et al (2006) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials. J Clin Oncol 24:2028–2037. https://doi.org/10.1200/JCO.2005.04.3273

Article  PubMed  Google Scholar 

van Laar C, van der Sangen MJC, Poortmans PMP et al (2013) Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients. Eur J Cancer 49:3093–3101. https://doi.org/10.1016/j.ejca.2013.05.030

Article  PubMed  Google Scholar 

Poortmans PMP, Arenas M, Livi L (2017) Over-irradiation. Breast 31:295–302. https://doi.org/10.1016/j.breast.2016.07.022

Article  PubMed  Google Scholar 

Roché H, Fumoleau P, Spielmann M et al (2006) Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 trial. JCO 24:5664–5671. https://doi.org/10.1200/JCO.2006.07.3916

Article  CAS  Google Scholar 

Spielmann M, Roché H, Delozier T et al (2009) Trastuzumab for patients with axillary-node-positive breast cancer: results of the FNCLCC-PACS 04 trial. J Clin Oncol 27:6129–6134. https://doi.org/10.1200/JCO.2009.23.0946

Article  CAS  PubMed  Google Scholar 

Moossdorff M, van Roozendaal LM, Strobbe LJA et al (2014) Maastricht delphi consensus on event definitions for classification of recurrence in breast cancer research. JNCI: J Natl Cancer Inst. https://doi.org/10.1093/jnci/dju288

Article  PubMed  PubMed Central  Google Scholar 

Elkhuizen PH, van de Vijver MJ, Hermans J et al (1998) Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40:859–867. https://doi.org/10.1016/s0360-3016(97)00917-6

Article  CAS  PubMed  Google Scholar 

Elkhuizen PH, Hermans J, Leer JW, van dE Vijver MJ (2001) Isolated late local recurrences with high mitotic count and early local recurrences following breast-conserving therapy are associated with increased risk on distant metastasis. Int J Radiat Oncol Biol Phys 50:387–396. https://doi.org/10.1016/s0360-3016(01)01469-9

Article  CAS  PubMed  Google Scholar 

Melvin JC, Purushotham AD, Garmo H et al (2016) Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time. Br J Cancer 114:88–95. https://doi.org/10.1038/bjc.2015.314

Article  PubMed  Google Scholar 

Nguyen PL, Taghian AG, Katz MS et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373–2378. https://doi.org/10.1200/JCO.2007.14.4287

Article  PubMed  Google Scholar 

Arvold ND, Taghian AG, Niemierko A et al (2011) Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 29:3885–3891. https://doi.org/10.1200/JCO.2011.36.1105

Article  PubMed  PubMed Central  Google Scholar 

Dominici LS, Mittendorf EA, Wang X et al (2012) Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res 14:R82. https://doi.org/10.1186/bcr3197

Article  PubMed  PubMed Central  Google Scholar 

Moo T-A, McMillan R, Lee M et al (2014) Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1–T2 breast cancer and 1–3 positive lymph nodes. Ann Surg Oncol 21:1569–1574. https://doi.org/10.1245/s10434-014-3488-x

Article  PubMed  PubMed Central  Google Scholar 

Fisher B, Bryant J, Dignam JJ et al (2002) Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141–4149. https://doi.org/10.1200/JCO.2002.11.101

Article  CAS  PubMed  Google Scholar 

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–1716. https://doi.org/10.1016/S0140-6736(11)61629-2

Article  Google Scholar 

Fitzal F, Filipits M, Rudas M et al (2015) The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial. Br J Cancer 112:1405–1410. https://doi.org/10.1038/bjc.2015.98

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colleoni M, Sun Z, Price KN et al (2016) Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V. J Clin Oncol 34:927–935. https://doi.org/10.1200/JCO.2015.62.3504

Article  CAS  PubMed  PubMed Central  Google Scholar 

Voogd AC, Nielsen M, Peterse JL et al (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19:1688–1697. https://doi.org/10.1200/JCO.2001.19.6.1688

Article  CAS  PubMed  Google Scholar 

Han W, Kim SW, Ae Park I et al (2004) Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 4:82. https://doi.org/10.1186/1471-2407-4-82

Article  PubMed  PubMed Central  Google Scholar 

De La Cruz L, Blankenship SA, Chatterjee A et al (2016) Outcomes after oncoplastic breast-conserving surgery in breast cancer patients: a systematic literature review. Ann Surg Oncol 23:3247–3258. https://doi.org/10.1245/s10434-016-5313-1

Article  PubMed  Google Scholar 

Moran MS, Schnitt SJ, Giuliano AE et al (2014) Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol 32:1507–1515. https://doi.org/10.1200/JCO.2013.53.3935

Article  PubMed  Google Scholar 

Fisher B, Redmond C, Poisson R et al (1989) Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822–828. https://doi.org/10.1056/NEJM198903303201302

Article  CAS  PubMed  Google Scholar 

Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation f